Work

A phase I trial of the farnesyltransferase (FT) inhibitor, BMS-214662 (B) in combination with paclitaxel (P) and carboplatin (C) in patients with advanced cancer

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.3066

Authors: G. K. Dy, L. M. Bruzek, G. A. Croghan, S. Mandrekar, P. Peethambaram, L. J. Hanson, C. Erlichman, S. Cheng

Institutions: Mayo Clinic, Bristol-Myers Squibb (United States)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595952518

Cites:

Cited by: 2

Related to: 10